# FDA Inspection 982647 - SPI Pharma, Inc. - August 24, 2016

Source: https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/e187d5c6-92fd-469b-9513-63a1ea9df5aa
Source feed: FDA_Inspections

> FDA Inspection 982647 for SPI Pharma, Inc. on August 24, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 982647
- Company Name: SPI Pharma, Inc.
- Inspection Date: 2016-08-24
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1229889 - 2024-02-01](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/00c9d7dc-44e6-4f3c-9223-f734ca8ab96b)
- [FDA Inspection 1030110 - 2017-09-28](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/6f5b5ee5-eb92-4af7-b524-f0ae56de1908)
- [FDA Inspection 800169 - 2012-09-07](https://www.keypedia.com/records/fda_inspections/spi-pharma-inc/813b8338-b047-4c62-adc1-66f1f4424c12)

Company: https://www.keypedia.com/companies/spi-pharma-inc/60ad79e7-93e1-4507-b543-b94916c39698

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c